264 related articles for article (PubMed ID: 21515913)
21. Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.
Zheng C; Jia W; Tang Y; Zhao H; Jiang Y; Sun S
J Exp Clin Cancer Res; 2012 Oct; 31(1):84. PubMed ID: 23034174
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells.
Inoue-Mochita M; Inoue T; Kojima S; Futakuchi A; Fujimoto T; Sato-Ohira S; Tsutsumi U; Tanihara H
J Biol Chem; 2018 Jul; 293(28):10975-10984. PubMed ID: 29752408
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line.
Fenton JI; Hursting SD; Perkins SN; Hord NG
Carcinogenesis; 2006 Jul; 27(7):1507-15. PubMed ID: 16597643
[TBL] [Abstract][Full Text] [Related]
24. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.
Horiuchi S; Yamamoto N; Dewan MZ; Takahashi Y; Yamashita A; Yoshida T; Nowell MA; Richards PJ; Jones SA; Yamamoto N
Int J Cancer; 2006 Aug; 119(4):823-30. PubMed ID: 16557588
[TBL] [Abstract][Full Text] [Related]
25. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
Gaillard JP; Liautard J; Klein B; Brochier J
Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
27. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
Vermes C; Jacobs JJ; Zhang J; Firneisz G; Roebuck KA; Glant TT
J Biol Chem; 2002 May; 277(19):16879-87. PubMed ID: 11884403
[TBL] [Abstract][Full Text] [Related]
28. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells.
Yi H; Cho HJ; Cho SM; Jo K; Park JA; Kim NH; Amidon GL; Kim JS; Shin HC
Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503
[TBL] [Abstract][Full Text] [Related]
29. IL-6 trans-signaling is another pathway to upregulate Osteopontin.
Uchibori T; Matsuda K; Shimodaira T; Sugano M; Uehara T; Honda T
Cytokine; 2017 Feb; 90():88-95. PubMed ID: 27863335
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.
Santer FR; Malinowska K; Culig Z; Cavarretta IT
Endocr Relat Cancer; 2010 Mar; 17(1):241-53. PubMed ID: 19966016
[TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
32. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells.
Jiang XP; Yang DC; Elliott RL; Head JF
Anticancer Res; 2011 Sep; 31(9):2899-906. PubMed ID: 21868536
[TBL] [Abstract][Full Text] [Related]
34. Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.
Okugawa Y; Miki C; Toiyama Y; Yasuda H; Yokoe T; Saigusa S; Hiro J; Tanaka K; Inoue Y; Kusunoki M
Br J Cancer; 2010 Sep; 103(6):787-95. PubMed ID: 20823887
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
[TBL] [Abstract][Full Text] [Related]
36. EZH2 promotes angiogenesis in peritoneal dialysis by epigenetically activating SP4 expression in the IL-6/sIL-6R signalling pathway.
Zhu N; Guan H; Wang X; Zhang Y; Gu L; Jia J; Wang L; Yuan W
Int J Med Sci; 2023; 20(1):114-124. PubMed ID: 36619221
[No Abstract] [Full Text] [Related]
37. Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Kleinegger F; Hofer E; Wodlej C; Golob-Schwarzl N; Birkl-Toeglhofer AM; Stallinger A; Petzold J; Orlova A; Krassnig S; Reihs R; Niedrist T; Mangge H; Park YN; Thalhammer M; Aigelsreiter A; Lax S; Garbers C; Fickert P; Rose-John S; Moriggl R; Rinner B; Haybaeck J
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):308-321. PubMed ID: 30419338
[TBL] [Abstract][Full Text] [Related]
38. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
[TBL] [Abstract][Full Text] [Related]
39. Synergistic action of Flt3 and gp130 signalings in human hematopoiesis.
Ebihara Y; Tsuji K; Lyman SD; Sui X; Yoshida M; Muraoka K; Yamada K; Tanaka R; Nakahata T
Blood; 1997 Dec; 90(11):4363-8. PubMed ID: 9373247
[TBL] [Abstract][Full Text] [Related]
40. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]